alphacyberrangerDoctors in England told not to start new patients on ADHD drugs due to shortage
SameOldJortsFrom the article: Henry Shelford, the CEO and a co-founder of ADHD UK, said: “ADHD is a disability and the sudden removal of medication is akin to removing a wheelchair from a disabled person that needs it.”
Ok, but you’re still refusing to let another disabled person have a wheelchair in the first place so…
While technically right, Ritalin / Concerta gets prescribed to a lot of people that don’t even need it; pushed by the pharmaceutical companies.
As far as I have followed this issue, this is a US problem. Pharmaceuticals are treated very differently in Europe. For example, there’s no public ads for prescription drugs allowed, meaning that patients usually don’t push doctors to prescribe random stuff they’ve heard about on TV.
Maybe not that way around, but in the EU the pharmaceutical companies take physicians out for dinner, take them on skiing trips etc. to accomplish the same result; push for more of this medication to be prescribed.
People downvoting me probably don’t work in healthcare and have no idea how these businesses work.
In the UK the NHS uses NICE guidelines for prescriptions. A doctor would be expected to justify prescribing outside of this.
Additionally, ADHD charities report that it is under diagnosed in people in the UK. With many parents suspicious of medicating children.
Have you actually read the article?
AnyOldName3Unfortunately, that study was done a couple of hundred years after the UK lost control of North Carolina, so it doesn’t support the claim that ADHD medication is overprescribed in the UK.
Oh my fault, I thought “globally” included the UK too.
This is a little misleading. Like most macro trends, the actual situation is far more complicated. Here’s a study describing under diagnosis of ADHD in adults
While it’s likely true that the condition is overdiagnosed in adolescent populations, it’s also widely acknowledged that ADHD is less commonly diagnosed once in adulthood.
Adult ADHD: Underdiagnosis of a Treatable Condition
Attention-deficit/hyperactivity disorder is a common neurodevelopmental disorder, well-characterized within the pediatric population and representing one of the most prevalent mental conditions among children and adolescents. Once diagnosed, pharmacologic ...
TipponNorth Carolina is neither in the UK or Europe
Can’t understand the word “globally” can you?
Your quote doesn’t say they calculate the result globally. It’s estimated based on the results in Carolina. They say estimate because the don’t have the data to say it is true.
ADHD administrative prevalence (based on rates of diagnosis and/or prescriptions) in children and adolescents in the UK has been estimated to fall between 0.2 and 0.9% since the mid-2000s (39). These rates remain below community prevalence estimates in the UK estimated at around 2.2% in 1999 and 2005 (55, 56), with more recent estimates of 1.6% in 2017, based on the more restrictive ICD-10 Hyperkinetic Disorder criteria (57). Administrative prevalence of adult ADHD in the UK stands at around 0.1% (40), far below even some of the lowest prevalence rates documented in adults (9).
- Failure of Healthcare Provision for Attention-Deficit/Hyperactivity Disorder in the United Kingdom: A Consensus Statement, 2021
This suggests about 1% of the UK population has ADHD and isn’t diagnosed. The would be more than 600,000 people.
You were replying to a comment on ADHD in the UK
Which is still a part of “globally”.